301 companies
NITE
Nightstar Therapeutics Plc
Nightstar Therapeutics plc is a clinical-stage gene therapy holding company, which engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases.
Massachusetts
NASDAQ
NVAX
Novavax, Inc.
novavax, inc.
Maryland
NASDAQ
OKYO
OKYO Pharma Ltd
OKYO Pharma Limited (NASDAQ: OKYO) is a clinical stage biopharmaceutical company developing innovative therapies for the treatment of DED and NCP, with ordinary shares listed for trading on the NASDAQ Capital Market.
United Kingdom
NASDAQ
OCGN
Ocugen Inc
ocugen, inc., is a rapidly growing ophthalmology company developing a rich clinical pipeline of innovative therapies that address rare and underserved ocular disorders.
Pennsylvania
NASDAQ
AYLA
Old Ayala, Inc
Ayala Pharmaceuticals, Inc.
Delaware
NASDAQ
OMGA
Omega Therapeutics Inc
omega therapeutics™ is a preclinical stage genomic medicine enterprise transforming medicine and patient care through precision genomic control.
Massachusetts
NASDAQ
OPT
Opthea Limited
opthea limited (formerly circadian technologies) is a public australian biotechnology company developing novel biologic therapies for the treatment of eye diseases.
Australia
NASDAQ
ORTX
Orchard Therapeutics plc
orchard therapeutics is dedicated to bringing transformative gene therapies to children with life-threatening orphan diseases.
United Kingdom
NASDAQ
OCEL
Organicell Regenerative Medicine, Inc.
Organicell Regenerative Medicine, Inc.
Florida
OTC
ONVO
Organovo Holdings Inc
organovo (nyse mkt: onvo) designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications.
California
NASDAQ
OTLK
Outlook Therapeutics Inc
overview oncobiologics is a pure-play complex biosimilar company focused on technically challenging and commercially attractive monoclonal antibodies (mabs), in the therapeutic areas of immunology and oncology.
New Jersey
NASDAQ
OYST
Oyster Point Pharma, Inc.
Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases.
New Jersey
NASDAQ
PDLI
PDL Biopharma Inc
PDL BioPharma, Inc.
Nevada
NASDAQ
PHXM
PHAXIAM Therapeutics S.A.
founded in 2004, erytech is a biopharmaceutical company developing innovative therapies to target unmet medical needs, particularly in the fields of cancer and orphan diseases.
France
NASDAQ
PALI
Palisade Bio Inc
Palisade Bio is a biopharmaceutical company focused on developing therapeutics that protect the integrity of the intestinal barrier.
California
NASDAQ
Parker H Stewart
Washington
PASG
Passage Bio Inc
passage bio, inc., a genetic medicines company, develops transformative therapies for rare monogenic central nervous system (cns) diseases.
Pennsylvania
NASDAQ
PKBO
Peak Bio, Inc.
Peak Bio is a clinical-stage biopharmaceutical company focused on commercializing innovative therapeutics that aim to improve and address significant unmet medical need for patients with inflammatory, rare and specialty diseases and cancer.
California
NASDAQ
PLTX
Peloton Therapeutics, Inc.
Texas
PMCB
PharmaCyte Biotech Inc
pharmacyte biotech, inc., a clinical stage biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the united states.
California
NASDAQ